期刊文献+

射频消融联合免疫治疗用于恶性肿瘤进展 被引量:2

Progresses of radiofrequency ablation combined with immunotherapy for malignant tumors
下载PDF
导出
摘要 针对恶性肿瘤的免疫治疗主要包括免疫检查点抑制剂、过继细胞疗法和疫苗治疗,但受益人群有限。射频消融(RFA)现已广泛用于局部治疗恶性肿瘤,且具有远隔效应和增强肿瘤免疫应答作用。RFA联合免疫治疗具有较单纯治疗更好的效果。本文就RFA联合免疫治疗用于恶性肿瘤进展进行综述。 Immunotherapy for malignant tumors included immune checkpoint inhibitor,adoptive cell therapy and vaccine treatment,but the beneficiaries remained limited.Radiofrequency ablation(RFA)had been widely used for local treatment of malignant tumors,with the effect of distancing and enhancing tumor immune response.RFA combined with immunotherapy had better efficacy than simple treatment of malignant tumors.The progresses of RFA combined with immunotherapy for malignant tumors were reviewed in this article.
作者 张忠亮 陈泽南 孟亮亮 张肖 ZHANG Zhongliang;CHEN Zenan;MENG Liangliang;ZHANG Xiao(Department of Radiology,the First Medical Center,Chinese PLA General Hospital,Beijing 100853,China;Graduate School,Chinese PLA Medical School,Beijing 100853,China;Department of Radiology,Chinese PAP Force Hospital of Beijing,Beijing 100853,China)
出处 《中国介入影像与治疗学》 北大核心 2023年第9期566-569,共4页 Chinese Journal of Interventional Imaging and Therapy
基金 联勤保障部队装备军内科研科学研究项目(LB2022B010100)。
关键词 肿瘤 射频消融 免疫治疗 neoplasms radiofrequency ablation immunotherapy
  • 相关文献

参考文献1

二级参考文献2

共引文献1

同被引文献163

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部